We are Inceptua

Helping patients and partners since 1997

 

Inceptua Group – global service partner for pharma and biotech – works with life sciences companies of all sizes, drawing on over 25 years of industry experience. The group was founded in 1997, initially focused on providing medication for named patient programs, and delivering products and services for clinical trials. 

 

Today, Inceptua is a global pharmaceutical services company with market-leading capabilities across multiple business areas.

 

Inceptua Clinical Trial Supply & Clinical Services provides clinical trial supply, services and logistics, including comparator sourcing of medicines, packaging, labelling, storage, and distribution services.

 

Inceptua Early Access & Unlicensed Medicines offers strategic advice, design, facilitation, and implementation of global early access programs, and distributes unlicensed and other medicines worldwide.

 

Inceptua has global operations with offices across Europe, North America and Asia.

Helping Pharma.
Helping Patients

 

We help pharmaceutical companies and healthcare professionals to access treatment for patients in need worldwide. 

 

As a specialized service partner with expert teams across the globe we:

 

  • Provide global comparator sourcing solutions and services for clinical trials
  • Facilitate early access and unlicensed medicines programs
  • Distribute medicines worldwide 

Quality is key

At Inceptua, Quality is more than just a department; it’s a fundamental part of our business. Across all our services and locations, we are committed to providing high quality products and services in compliance with regulatory standards. We operate a harmonized global Quality Management System (QMS) that is continually audited and reviewed under the leadership of our Quality Assurance and Regulatory Affairs teams.

All our affiliates are licensed and audited in accordance with the local health authority requirements. You can access copies of our licenses via the links below:

For any quality related queries,
please email our quality team:
quality@inceptua.com

Executive Leadership Team

About

With a solid pharmaceutical industry background in marketing, sales, and corporate development, Stefan leads the Inceptua Group.
CHIEF EXECUTIVE OFFICER

Stefan Fraenkel

About

Martin is CFO, in charge of Inceptua Groups financial department and sits on the company’s Board.
CHIEF FINANCIAL OFFICER

Martin Ridler

About

Mark has over 20 years of experience in clinical trial supplies, clinical services, pre-approval access, and business development, and leads our global Clinical Trial Supply team.
CHIEF COMMERCIAL OFFICER
EVP, CLINICAL TRIAL SERVICES

Mark Ware

About

Industry expert Annika leads our global supply chain and operations, and ensures best-in-class supply chain solutions for our clients.
EXECUTIVE VICE PRESIDENT
GLOBAL SUPPLY CHAIN AND OPERATIONS

Annika Kollén

About

Stuart is responsible for Inceptua's Early Access business unit, supporting pharmaceutical and biotech companies in making their medicines available to patients in need before commercialization.
EXECUTIVE VICE PRESIDENT
INCEPTUA EARLY ACCESS

Stuart Bell

About

Nathalie leads HR across all our locations. She has broad experience of organizational development, HR transformation, and international relations.
EXECUTIVE VICE PRESIDENT
GLOBAL HR, QA & COMPLIANCE

Nathalie Penndorf

About

With a Diploma in Biotechnology (Dipl.Ing.) and law degrees (registered as Syndikusrechtsanwalt), Steffi is the General Counsel of Inceptua Group.
GENERAL COUNSEL

Steffi Bross

Board of Directors

EXECUTIVE CHAIRMAN

Doug Cook

Member of the Board

Heyward Donigan

Member of the Board

Larry Marsh

Member of the Board

Adam Feinstein

Member of the board

Blake Goodner

MEMBER OF THE BOARD

Alan Raffensperger

Member of the Board

Chris Hasslinger

CEO and Board Member

Stefan Fraenkel

Join our team

The right people with the right values are critical to our mission – Helping Pharma. Helping Patients. With a diverse range of backgrounds, abilities, and skills, our team is our strongest asset. We are always looking for globally-minded people who are able to navigate rapidly changing environments.

We look for people who balance discipline and flexibility; people with expertise who show initiative and an ability to think outside the box. We offer generous compensation packages, training and development opportunities to support your growth. Sounds like you?

We welcome all applications at recruitment@inceptua.com

Deadline
As soon as possible

Accounts Receivable (AR) Analyst

Full-time

Lugano (Switzerland)

Recruitment Data Policy

Data obtained during recruitment will only be kept until either your application has been declined and then destroyed after 6 months. 

If your application is successful, the application documents will be saved at least for the duration of your employment at Inceptua.

We will only use your personal information for the purposes for which we collected it, i.e. for the recruitment exercise for which you have applied. However, if your job application is unsuccessful, Inceptua may wish to keep your personal information on file for in case there are future suitable employment opportunities with us.

We will ask for your consent before we keep your personal information on file for this purpose. 

Your consent can be withdrawn at any time. Your personal information will only be shared internally within Inceptua for the purposes of the recruitment exercise.

Your rights:

  1. Access and obtain a copy of your data on request;
  2. Require Inceptua to change incorrect or incomplete data;
  3. Require Inceptua to delete your data;
  4. Object to the processing of your data where the organization is relying on its legitimate interests as the legal ground for processing;
  5. Require Inceptua to restrict processing of your data;
  6.  Right to data portability;

If you have any questions about this privacy notice or about how we handle your personal information or you want to exercise any of your rights as data subject, please contact Inceptua’s DPO at privacy@inceptua.com

BIO

Executive Chairman

Doug Cook

Doug Cook is the Executive Chairman at Inceptua. Mr. Cook began his career driving the early success of Livingston Healthcare, leading to the purchase by UPS to become what is today UPS’s Global Healthcare business. After Livingston Healthcare, Mr. Cook moved to AmerisourceBergen (now called Cencora/COR) in 1998 and had an impressive career overseeing most of Cencora’s high growth, manufacturer-facing business. Mr. Cook ultimately served as the Executive Vice President, President Commercialization and Animal Health for COR.

BIO

Member of the Board

Heyward Donigan

Heyward Donigan is a seasoned healthcare CEO, Board Member, and Private Equity Advisor with broad industry experience and a track record of profitable growth. From 2019 to 2023, Ms. Donigan served as Rite Aid’s president and chief executive officer, making her one of the few women CEOs of a Fortune 500 company. While at Rite Aid, Ms. Donigan led the company to through a major brand, merchandise and technology transformation, debt reduction/refinancing, while also leading the company through a pandemic. Ms.Donigan is currently a strategic advisor to Vesey Street Capital Partners, Arima Health, and a board member of OnMed.

BIO

Member of the Board

Larry Marsh

Larry is a General Partner of Vesey Street Capital Partners and serves as a member of the Firm’s Investment Committee. He joined VSCP in 2016, and currently sits on the Board of QualityMetric, Safecor Health, and HRGi. He is responsible for portfolio company management and for evaluating new investment opportunities. Prior to VSCP, Larry was EVP, New Market Development & Chief Strategy Officer at Fortune 10 AmerisourceBergen. Prior to that, Larry was the #1 ranked Healthcare Technology & Distribution analyst on Wall Street for over a decade, at Barclays, Lehman Brothers, Salomon Smith Barney, and Wheat First Butcher & Singer. Larry worked with Adam, Bryan, Dan, and Joe at Barclays and Lehman. Larry received a B.S. in Economics & Management as well as an M.B.A. from the University of Richmond, and an M.P.H. from Columbia University.

BIO

Member of the Board

Adam Feinstein

Adam Feinstein is the Managing Partner of Vesey Street Capital Partners. Mr. Feinstein has 30 years of investment experience exclusively in the healthcare services sector. Prior to founding Vesey Street Capital Partners in 2014, he was a Managing Director on Wall Street and a healthcare industry executive. He held the position of Senior Vice President of Corporate Development, Strategic Investments, and Office of the Chief Executive Officer at LabCorp. Before his tenure at LabCorp, he spent 14 years as the Managing Director in Equity Research at Lehman Brothers/Barclays Capital. Mr. Feinstein is the Chairman of VSCP’s investment committee. He is also actively involved in working with portfolio company executives and sourcing new investment opportunities. At the same time, he oversees all of the firm’s investment activities and employees.

BIO

Member of the Board

Blake Goodner

Blake Goodner is a founder member of the investment firm Bridger Capital. He previously worked as a healthcare analyst at Tiger Management and a healthcare investment banker at Morgan Stanley. He currently serves as an advisor and board member for a range of healthcare companies. Mr. Goodner has been a member of the Trinity College Board of Visitors and the Duke Annual Fund Executive Committee. He is a current advisory board member with The Duke Margolis-Center for Health Policy.

BIO

Executive Vice Chairman

Alan Raffensperger

Alan Raffensperger has a robust leadership background in the pharmaceutical industry, having served as CEO of Inceptua and COO of Sobi (Swedish Orphan Biovitrum), along with significant international executive roles at Amgen, Roche, and Pharmacia.

He has also been CEO for venture capital-owned medical device companies, showcasing his versatility in healthcare leadership. Alan’s early career as an advanced life support paramedic provided a strong foundation in emergency healthcare.

He holds an MBA and a BA in Emergency Health Care Management.

BIO

Member of the Board

Chris Hasslinger

Chris Hasslinger is a Partner of Vesey Street Capital Partners and serves as a member of the Firm’s Investment Committee. He joined VSCP in 2023 and is responsible for sourcing and evaluating new investment opportunities and general portfolio company management. Mr. Hasslinger has nearly three decades of experience in healthcare and technology strategy and deal-making within the industry as well as in investment banking and private equity. He has extensive M&A experience, having closed over $20 billion in transaction value, and has established and structured a number of large commercial partnerships.

BIO

CEO and Board Member

Stefan Fraenkel

Stefan Fraenkel is the CEO of the Inceptua Group and is also on the Inceptua Board. He has extensive experience in the pharmaceutical industry. Before joining Inceptua, he held senior management positions at Sobi (Swedish Orphan Biovitrum), Sweden’s largest publicly listed specialty pharmaceutical company, leading Marketing & Sales and serving as Head of Corporate Development and Strategy.

Previously, Stefan worked at Pfizer and Wyeth in international commercial leadership roles across Europe and the USA, gaining deep insights into global pharmaceutical markets and strategies. Stefan has also spent part of his career in management consulting. Stefan holds a PhD in International Economics, an MBA, and a BSc in Engineering.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.